Barbara Stecca

4.8k total citations
65 papers, 3.8k citations indexed

About

Barbara Stecca is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Barbara Stecca has authored 65 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 20 papers in Oncology and 9 papers in Genetics. Recurrent topics in Barbara Stecca's work include Hedgehog Signaling Pathway Studies (32 papers), Epigenetics and DNA Methylation (13 papers) and Genomics and Chromatin Dynamics (10 papers). Barbara Stecca is often cited by papers focused on Hedgehog Signaling Pathway Studies (32 papers), Epigenetics and DNA Methylation (13 papers) and Genomics and Chromatin Dynamics (10 papers). Barbara Stecca collaborates with scholars based in Italy, United States and Switzerland. Barbara Stecca's co-authors include Ariel Ruiz i Altaba, Silvia Pietrobono, Christophe Mas, Valentina Montagnani, Silvia Pandolfi, Sinforosa Gagliardi, Elisabetta Rovida, Vincent Piguet, Rafael Correa‐Rocha and Marie Zbinden and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Barbara Stecca

65 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Stecca Italy 32 3.2k 1.2k 516 390 328 65 3.8k
Lucia Di Marcotullio Italy 38 3.5k 1.1× 958 0.8× 449 0.9× 1.0k 2.6× 206 0.6× 90 4.1k
Bruno Alicke United States 21 1.8k 0.6× 566 0.5× 328 0.6× 215 0.6× 233 0.7× 32 2.3k
Enrica Martinelli Italy 23 1.5k 0.5× 1.0k 0.9× 322 0.6× 502 1.3× 171 0.5× 44 3.1k
Angeliki Malliri United Kingdom 32 2.5k 0.8× 928 0.8× 185 0.4× 380 1.0× 175 0.5× 60 3.5k
Kevin G. Leong United States 15 1.9k 0.6× 1.3k 1.0× 384 0.7× 638 1.6× 137 0.4× 18 3.1k
Stéphane Ansieau France 24 3.1k 1.0× 2.4k 1.9× 384 0.7× 1.1k 2.9× 205 0.6× 48 4.6k
Joan Levy United States 28 2.6k 0.8× 955 0.8× 250 0.5× 406 1.0× 188 0.6× 58 3.6k
Wendy C. Weinberg United States 33 1.8k 0.6× 1.1k 0.9× 269 0.5× 439 1.1× 198 0.6× 53 3.2k
Norbert Schweifer Austria 28 2.8k 0.9× 1.1k 0.9× 1.1k 2.1× 660 1.7× 283 0.9× 46 4.0k
Byungwoo Ryu United States 20 1.7k 0.5× 1.3k 1.1× 216 0.4× 568 1.5× 162 0.5× 39 2.9k

Countries citing papers authored by Barbara Stecca

Since Specialization
Citations

This map shows the geographic impact of Barbara Stecca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Stecca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Stecca more than expected).

Fields of papers citing papers by Barbara Stecca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Stecca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Stecca. The network helps show where Barbara Stecca may publish in the future.

Co-authorship network of co-authors of Barbara Stecca

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Stecca. A scholar is included among the top collaborators of Barbara Stecca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Stecca. Barbara Stecca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marranci, Andrea, et al.. (2025). PARP1 in melanoma: Mechanistic insights and implications for basic and clinical research. Cancer Letters. 617. 217599–217599. 1 indexed citations
2.
Gardini, Lucia, Matteo Lulli, Ignazia Tusa, et al.. (2024). Importin subunit beta‐1 mediates ERK5 nuclear translocation, and its inhibition synergizes with ERK5 kinase inhibitors in reducing cancer cell proliferation. Molecular Oncology. 19(1). 99–113. 3 indexed citations
3.
Stecca, Barbara, et al.. (2023). Emerging Roles of Hedgehog Signaling in Cancer Immunity. International Journal of Molecular Sciences. 24(2). 1321–1321. 28 indexed citations
4.
Pepe, Sara, Giuseppe Giannini, Serena Sestini, et al.. (2023). Targeting GLI1 and GLI2 with small molecule inhibitors to suppress GLI-dependent transcription and tumor growth. Pharmacological Research. 195. 106858–106858. 16 indexed citations
5.
Pietrobono, Silvia, Andrea Marranci, Ilaria Battisti, et al.. (2022). p38 MAPK-dependent phosphorylation of transcription factor SOX2 promotes an adaptive response to BRAF inhibitors in melanoma cells. Journal of Biological Chemistry. 298(9). 102353–102353. 4 indexed citations
6.
Manetti, Fabrizio, Sara Pepe, Elena Cini, et al.. (2022). Quinolines and Oxazino-quinoline Derivatives as Small Molecule GLI1 Inhibitors Identified by Virtual Screening. ACS Medicinal Chemistry Letters. 13(8). 1329–1336. 7 indexed citations
7.
Raggi, Chiara, Mirella Pastore, Laura Carrassa, et al.. (2022). Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma. Molecular Cancer Therapeutics. 22(3). 343–356. 1 indexed citations
8.
Tusa, Ignazia, Sinforosa Gagliardi, Matteo Lulli, et al.. (2021). Inhibition of ERK5 Elicits Cellular Senescence in Melanoma via the Cyclin-Dependent Kinase Inhibitor p21. Cancer Research. 82(3). 447–457. 29 indexed citations
9.
Manetti, Fabrizio, et al.. (2020). Pharmacophore-Based Virtual Screening for Identification of Negative Modulators of GLI1 as Potential Anticancer Agents. ACS Medicinal Chemistry Letters. 11(5). 832–838. 16 indexed citations
10.
Andreucci, Elena, Silvia Peppicelli, Jessica Ruzzolini, et al.. (2020). The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells. Journal of Molecular Medicine. 98(10). 1431–1446. 69 indexed citations
11.
Montagnani, Valentina, et al.. (2020). E3 ubiquitin ligase PARK2, an inhibitor of melanoma cell growth, is repressed by the oncogenic ERK1/2-ELK1 transcriptional axis. Journal of Biological Chemistry. 295(47). 16058–16071. 11 indexed citations
12.
Tusa, Ignazia, Sinforosa Gagliardi, Silvia Pandolfi, et al.. (2018). ERK5 is activated by oncogenic BRAF and promotes melanoma growth. Oncogene. 37(19). 2601–2614. 53 indexed citations
13.
Buonvicino, Daniela, Francesca Mazzola, Federica Zamporlini, et al.. (2018). Identification of the Nicotinamide Salvage Pathway as a New Toxification Route for Antimetabolites. Cell chemical biology. 25(4). 471–482.e7. 52 indexed citations
14.
Pietrobono, Silvia, Sinforosa Gagliardi, David Colecchia, et al.. (2018). Targeted inhibition of Hedgehog-GLI signaling by novel acylguanidine derivatives inhibits melanoma cell growth by inducing replication stress and mitotic catastrophe. Cell Death and Disease. 9(2). 142–142. 40 indexed citations
15.
Pandolfi, Silvia, Valentina Montagnani, Junia Y. Penachioni, et al.. (2012). WIP1 phosphatase modulates the Hedgehog signaling by enhancing GLI1 function. Oncogene. 32(40). 4737–4747. 41 indexed citations
16.
Stecca, Barbara & Ariel Ruiz i Altaba. (2009). A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers. The EMBO Journal. 28(6). 663–676. 200 indexed citations
17.
Stecca, Barbara, Christophe Mas, & Ariel Ruiz i Altaba. (2005). Interference with HH–GLI signaling inhibits prostate cancer. Trends in Molecular Medicine. 11(5). 199–203. 47 indexed citations
18.
Stecca, Barbara & Ariel Ruiz i Altaba. (2005). Brain as a paradigm of organ growth: Hedgehog–Gli signaling in neural stem cells and brain tumors. Journal of Neurobiology. 64(4). 476–490. 65 indexed citations
19.
Sánchez‐Gómez, Pilar, Ana Hernández, Barbara Stecca, et al.. (2004). Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling. Proceedings of the National Academy of Sciences. 101(34). 12561–12566. 423 indexed citations
20.
Gramantieri, Laura, Cinzia Melchiorri, Pasquale Chieco, et al.. (1996). Alteration of DNA ploidy and cell nuclearity in human hepatocellular carcinoma associated with HBV infection. Journal of Hepatology. 25(6). 848–853. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucia Di Marcotullio Breakdown of academic impact, for papers by Bruno Alicke Breakdown of academic impact, for papers by Enrica Martinelli Breakdown of academic impact, for papers by Angeliki Malliri Breakdown of academic impact, for papers by Kevin G. Leong Breakdown of academic impact, for papers by Stéphane Ansieau Breakdown of academic impact, for papers by Joan Levy Breakdown of academic impact, for papers by Wendy C. Weinberg Breakdown of academic impact, for papers by Norbert Schweifer Breakdown of academic impact, for papers by Byungwoo Ryu
Rankless by CCL
2026